Conditional logistic regression analysis of JAK2V617F in patients with ischemic stroke vs GESUS controls free of ischemic cerebrovascular disease (matched 1:3) according to their smoking history. The analyses are adjusted for hypertension, dyslipidemia, diabetes, ischemic heart disease, and atrial fibrillation.